Ketorolac in Acute Headache Management

R. Norman Harden*, Timothy D. Carter, Charles S. Gilman, Alan J. Gross, John R. Peters

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


SYNOPSIS Twelve patients presenting to an emergency department in headache crisis were treated with Ketorolac tromethamine 60 mg. intramuscularly. All improved sufficiently to require no further emergent treatment. There was statistically significant improvement on all segments of the short form McGill Pain Questionnaire. This open label trial suggests that Ketorolac Tromethamine may be a useful agent in the treatment of heed‐ache crisis, and a controlled study to examine this is warranted.

Original languageEnglish (US)
Pages (from-to)463-464
Number of pages2
JournalHeadache: The Journal of Head and Face Pain
Issue number7
StatePublished - Jul 1991


  • Ketorolac
  • acute

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Ketorolac in Acute Headache Management'. Together they form a unique fingerprint.

Cite this